Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
Status:
Completed
Trial end date:
2018-05-11
Target enrollment:
Participant gender:
Summary
To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1%
Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and
female adults